Non alcoholic fatty liver disease: what can we do about it?
Microsoft PowerPoint - NASH_2006.ppt [Read-Only]
Hepatosteatosis Prof Samir Helmy Assaad-Khalil Unit of Diabetes & Metabolism Alexandria Faculty of Medicine 2007.
PREVALENCE OF NAFLD IN DIABETIC PATIENTS The world-wide prevalence of non-alcoholic fatty liver disease (NAFLD) is: o Western countries: 15% to 40%
NAFLD Dr Allister J Grant Consultant Hepatologist.
NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES Mark Tutschka PGY3 Internal Medicine.